These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 2855247

  • 1. Para-bromophenacyl bromide inhibits endothelium-dependent arterial relaxation and cyclic GMP accumulation by effects produced exclusively in the smooth muscle.
    Johns RA, Peach MJ.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):859-65. PubMed ID: 2855247
    [Abstract] [Full Text] [Related]

  • 2. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
    Marczin N, Ryan US, Catravas JD.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):170-9. PubMed ID: 1328604
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [Abstract] [Full Text] [Related]

  • 4. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA, Peach MJ, Linden J, Tichotsky A.
    Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
    [Abstract] [Full Text] [Related]

  • 5. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA, Tichotsky A, Muro M, Spaeth JP, Le Cras TD, Rengasamy A.
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [Abstract] [Full Text] [Related]

  • 6. Use of cultured cells to study the relationship between arachidonic acid and endothelium-derived relaxing factor.
    Johns RA, Izzo NJ, Milner PJ, Loeb AL, Peach MJ.
    Am J Med Sci; 1988 Apr; 295(4):287-92. PubMed ID: 2834949
    [Abstract] [Full Text] [Related]

  • 7. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K, Berkowitz BA.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [Abstract] [Full Text] [Related]

  • 8. Endothelium-derived relaxing factor in cultured cells.
    Loeb AL, Johns RA, Milner P, Peach MJ.
    Hypertension; 1987 Jun; 9(6 Pt 2):III186-92. PubMed ID: 3036702
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 11. Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.
    Ignarro LJ, Harbison RG, Wood KS, Wolin MS, McNamara DB, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):560-9. PubMed ID: 2989487
    [Abstract] [Full Text] [Related]

  • 12. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
    Dong H, Waldron GJ, Galipeau D, Cole WC, Triggle CR.
    Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
    [Abstract] [Full Text] [Related]

  • 13. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries.
    Ohlmann P, Martínez MC, Schneider F, Stoclet JC, Andriantsitohaina R.
    Br J Pharmacol; 1997 Jun; 121(4):657-64. PubMed ID: 9208131
    [Abstract] [Full Text] [Related]

  • 14. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ, Buga GM, Byrns RE, Wood KS, Chaudhuri G.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F, Schmidt K, Nielsen EB, Mayer B.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [Abstract] [Full Text] [Related]

  • 17. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.
    Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):682-90. PubMed ID: 6323677
    [Abstract] [Full Text] [Related]

  • 18. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [Abstract] [Full Text] [Related]

  • 19. Endothelium-dependent relaxation to arachidonic acid in porcine coronary artery: is there a fourth pathway?
    Lonigro AJ, Weintraub NL, Branch CA, Stephenson AH, McMurdo L, Sprague RS.
    Pol J Pharmacol; 1994 Jun; 46(6):567-77. PubMed ID: 7620517
    [Abstract] [Full Text] [Related]

  • 20. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.